TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AVXL

Anavex Life Sciences Corp

Healthcare · Biotechnology

2.50$ +2.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AVXL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.07 0.12 0.21 0.26 0.30 0.46 0.43 0.47 0.49 0.55 0.50 0.44
0.23 0.26 0.24 0.12 0.13 0.14 0.10 0.13 0.17 0.15 0.13 0.16
0.30 0.38 0.42 0.38 0.43 0.59 0.53 0.60 0.66 0.70 0.63 0.60
-0.30 -0.38 -0.44 -0.38 -0.43 -0.59 -0.53 -0.60 -0.66 -0.60 -0.63 -0.60
0.00 0.00 0.32 0.00 0.00 0.00 0.08 0.06 0.01 0.01 0.00 0.00
-1.16 -0.65 -0.42 -0.33 -0.39 -0.54 -0.53 -0.54 -0.62 -0.60 -0.52 -0.54
0.00 0.00 0.00 0.00 0.00 0.00 -0.07 0.00 0.00 0.00 -0.03 -0.01
-1.16 -0.65 -0.42 -0.33 -0.39 -0.54 -0.45 -0.54 -0.62 -0.60 -0.52 -0.54
-1.18 -0.65 -0.43 -0.38 -0.43 -0.59 -0.53 -0.54 -0.62 -0.60 -0.52 -0.54

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?